Dr. Bernd Metzner to Become Chief Financial Officer of Gerresheimer AG on May 15, 2019

Tuesday, May 14, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

DUESSELDORF, Germany, May 14, 2019 /PRNewswire/ -- Dr. Bernd Metzner (48) takes up the position of Chief Financial Officer of Gerresheimer AG on May 15, 2019. Dr. Metzner had been Chief Financial Officer of SDAX-listed Ströer SE & Co. KGaA since 2014.

"I very much welcome the financial expertise and years of industry experience that Dr. Bernd Metzner brings to the Management Board. Together with him and Dr. Lukas Burkhardt,

we make a strong Management Board team that will drive Gerresheimer's sustainable growth forward," says Dietmar Siemssen, CEO of Gerresheimer AG.

After studying business administration in Siegen, Germany, completing his doctorate and starting his career at a law firm, Dr. Metzner held various management positions in finance at the Bayer Group between 2002 and 2011. Among other roles, he was responsible for coordinating the carve-out and initial public offering of Lanxess, and held the position of CFO at Bayer Italy as well as that of global CFO in Bayer's Pharmaceuticals Division. Before joining Ströer, he served as CFO of the global, family-owned Döhler Group from mid-2011 to mid-2014.

The Management Board of Gerresheimer AG (as of May 15, 2019):

  • Dietmar Siemssen, CEO responsible among other things for the Plastics & Devices and Advanced Technologies Divisions
  • Dr. Bernd Metzner, CFO
  • Dr. Lukas Burkhardt, Management Board member responsible for the Primary Packaging Glass Division

ContactGerresheimer AGKlaus-Bungert-Strasse 440468 DüsseldorfGermany

Jens KurtenGroup Senior Director Communications & MarketingPhone: +49 211 6181-250Telefax: +49 211 6181-241E-Mail: jens.kuerten@gerresheimer.comWebsite: www.gerresheimer.com

Cision View original content:http://www.prnewswire.com/news-releases/dr-bernd-metzner-to-become-chief-financial-officer-of-gerresheimer-ag-on-may-15-2019-300849535.html

SOURCE Gerresheimer AG



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store